Abstract
Trans-catheter Aortic Valve Replacement (TAVR) is a novel procedure that has revolutionized the treatment for severe aortic stenosis (AS). There is limited data on the pre-operative beta-blocker (BB) impact on TAVR outcomes. A Retrospective analysis of 373 patients with severe AS who underwent TAVR
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
